The Future of the GLP-1 Receptor Agonists.

JAMA · 2019

Last updated 2026-09-22

Journal	JAMA, 2019
Citations	24
Relative citation ratio	1.05
NIH percentile	52
Molecules	—
Conditions studied	Type 2 Diabetes, Obesity, Cardiovascular Risk Reduction, Chronic Kidney Disease, Mash, Obstructive Sleep Apnea, Pcos, Heart Failure

Full record and abstract on PubMed 30903797 ↗